Buy Saxenda (Liraglutide) 100 IU/ml Injection Pen Online

Saxenda (Liraglutide) 100 IU/ml is a prescription-only injectable medication used for weight management and obesity treatment in adults.
It is clinically approved in the EU and works as a GLP-1 receptor agonist, helping regulate appetite and reduce food intake.

Designed for adults with:

Obesity (BMI ≥30)
Overweight (BMI ≥27) with weight-related health conditions such as type 2 diabetes, high blood pressure, or sleep apnea.

Product Details for Saxenda (Lliraglutide)100 IU/ml

Brand Name: Saxenda
Active Ingredient: Liraglutide (100 IU/ml)
Form: Prefilled injection pen
Strengths: 6mg/ml, delivering up to 100 IU/ml per pen
Pack Options: 1, 3, 5 pens

Product Specification for Saxenda (Lliraglutide)100 IU/ml

Dose/Strength	6 mg/ml
Strength	100 IU/ml
Packaging Size	3 ml
Packaging Type	Box

Buy Saxenda (Lliraglutide)100 IU/ml Online | LegalMedSEU

Saxenda® (liraglutide) injection 3mg is an injectable prescription medicine used to help adults with excess weight (BMI 27) who also have weight-related medical problems or obesity (BMI 30), as well as children aged 12-17 years with a body weight greater than 132 pounds (60 kg) and obesity, lose weight and keep it off. Saxenda® should be used in conjunction with a low-calorie diet and increased physical exercise.

Saxenda® and Victoza® contain the same active component, liraglutide, and should not be used concurrently or in conjunction with other GLP-1 receptor agonist medications.

It is unknown whether Saxenda® is safe and effective when combined with other prescription, over-the-counter, or herbal weight-loss treatments.

It is unknown whether Saxenda® is safe and effective in children under the age of 12.It is unknown whether Saxenda® is safe and effective in type 2 diabetic youngsters aged 12 to 17 years.

Key Benefits of Saxenda (Lliraglutide)100 IU/ml

Supports clinically proven weight loss in adults
Helps regulate appetite and food cravings
Reduces calorie intake naturally
Works alongside a healthy diet & exercise program
EU-approved therapy with strong safety profile

Safety & Usage Information for Saxenda (Lliraglutide)100 IU/ml

Administration: Subcutaneous injection (under the skin), usually in the abdomen, thigh, or upper arm
Dosage: Start at 0.6mg daily and gradually increase to 3.0mg (as prescribed)
Do not exceed prescribed dosage
Common side effects: nausea, headache, mild stomach upset
Not recommended for individuals with a history of thyroid cancer, pancreatitis, or pregnant/breastfeeding women